Correction: The anti-tumor efficacy of CDK4/6 Inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

• Daniele Cretella,
• Andrea Ravelli,
• Claudia Fumarola,
• Silvia La Monica,
• Graziana Digiacomo,
• Andrea Cavazzoni,
• Roberta Alfieri,
• Alessandra Biondi,
• Daniele Generali,
• Mara Bonelli,
• Pier Giorgio Petronini

Affiliations

Daniele Cretella

Department of Medicine and Surgery, University of Parma

Andrea Ravelli

Department of Medicine and Surgery, University of Parma

Claudia Fumarola

Department of Medicine and Surgery, University of Parma

Silvia La Monica

Department of Medicine and Surgery, University of Parma

Graziana Digiacomo

Department of Medicine and Surgery, University of Parma

Andrea Cavazzoni

Department of Medicine and Surgery, University of Parma

Roberta Alfieri

Department of Medicine and Surgery, University of Parma

Alessandra Biondi

Department of Medicine and Surgery, University of Parma

Daniele Generali

Department of Medical, Surgery and Health Sciences, University of Trieste

Mara Bonelli

Department of Medicine and Surgery, University of Parma

Pier Giorgio Petronini

Department of Medicine and Surgery, University of Parma